NewLake's 'Direction of Travel' Turns Positive: Rescheduling, Uplist Optionality, and a Strengthened Balance Sheet

A Regulatory Clock Ticks Louder

For NewLake Capital Partners, the quiet revolution of the past quarter wasn't in the income statement—it was in the legal calendar. CEO Anthony Coniglio opened the Q2 2026 call by framing the medical rescheduling process as the most constructive period for cannabis in years, pointing to the New York Stock Exchange listings of Trulieve and Glasshouse as milestones that "reflect the continued normalization of the industry." “The rescheduling of medical cannabis to Schedule III the continued momentum toward broader reform and the New York Stock Exchange listings of Trulieve and Glasshouse are all meaningful milestones…” — Anthony Coniglio, President and Chief Executive Officer · 2026-08-06 Importantly, Coniglio said all of the company's medical-only tenants—representing 50% of the portfolio—have submitted DEA registration applications, a step he described as transforming "registered medical cannabis operators into federally legal businesses."

That optimism extends to a long-awaited potential uplist. Coniglio was characteristically measured:

We are not announcing anything today, but we are actively evaluating whether there is a path for New Lake to uplist to a major exchange.

The regulatory agenda also gave management room to strengthen tenant protections. In a nuanced move, NewLake negotiated an additional guarantee on the Acreage lease from Canopy USA, the parent entity that also holds Wana, Jetty, and TerrAscend shares. “Through dialogue and a transaction, earlier this year around Pennsylvania, we were able to negotiate an additional guarantee from Canopy USA.” — Anthony Coniglio, President and Chief Executive Officer · 2026-08-06 For a REIT that has always highlighted credit quality as its first line of defense, this is a substantive upgrade to the Canopy USA relationship.

Portfolio Watch: Cannabist and the Vacant Trio

The most immediate operational overhang remains the Cannabist portfolio. The tenant filed for bankruptcy in Canada, and now Vireo Growth has agreed to acquire certain assets across five markets, including the four properties NewLake leases in Illinois and Massachusetts. Management confirmed the tenant is current through August rent and is "actively engaged" to minimize disruption. “When someone acquires a license in an operating business, they typically will step into that facility and they will continue paying rent.” — Anthony Coniglio, President and Chief Executive Officer · 2026-08-06 That's the precedent—but Coniglio acknowledged that a purchaser may negotiate a rent reduction as part of a deal. The company still holds roughly one month of security deposits, offering a modest cushion. Management has long flagged Cannabist and Acreage as the tenants to watch; Chairman Gordon DuGan warned on the prior call, “I'd be more worried about Cannabist and Acreage” — Gordon DuGan, Chairman · 2026-03-06. The Vireo transaction does not remove that risk but provides a potential buyer.

Meanwhile, the three vacant cultivation facilities in Nevada, Pennsylvania, and Massachusetts remain a drag on rental income and add property-carrying costs. CFO Lisa Meyer noted Q1 is a better run-rate for those expenses; Q2 benefited from a one-time reimbursement. On the path to re-tenanting, Coniglio was pragmatic: “First off, our guiding principle when it comes to tenanting those facilities is what is the best net present value for our shareholders.” — Anthony Coniglio, President and Chief Executive Officer · 2026-08-06 This is a subtle but notable shift from prior calls, where management stressed cannabis-first re-leasing. "If you look at, say, in Nevada, we do see hemp as a real big issue," Coniglio added, and with hemp receding there has been renewed interest. But he was careful not to handicap timing: "Nothing's ever done till it is done."

Balance Sheet Stability Meets a Catalyst-Stacked Sector

Financially, the quarter was as steady as advertised. Total revenue was $12.1M, down from $12.9M a year ago, and FFO per share was $0.47, with AFFO per share of $0.49. The dividend of $0.43 per share equates to an 88% AFFO payout ratio, within the guided 80-90% range. Management also amended the $90M revolving credit facility in August, reducing the rate by 100 basis points (from Prime + 1% to Prime) and extending maturity to May 2029. “Our ability to extend our credit facility on improved terms while continuing to pursue accretive investment opportunities speaks to the strength of our balance sheet.” — Anthony Coniglio, President and Chief Executive Officer · 2026-08-06

The leverage story remains starkly conservative: only $7.6M drawn on the facility, debt-to-total-assets of 1.6%, and debt-to-EBITDA of roughly 0.2x. Funds From Operations came in at $9M in the latest quarter, down ~5% year-over-year but essentially flat for three years. That stability is a testament to the quality of the existing leases, but it also highlights how much growth potential is locked in the vacant assets. The stock is off 49.5% from its October 2021 peak, yet it has rallied 10.9% over the past 90 days—investors are starting to price in a more favorable regulatory tailwind.

NewLake's core thesis—disciplined underwriting, conservative leverage, and a focus on property-level cash flow—has not wavered. What has changed is the external environment: a tangible rescheduling timeline, potential uplist pathways, and neighboring operators finally trading on major exchanges. If the adult use wave builds momentum and the vacant plants find tenants, the earnings power of this portfolio could quickly revive. For now, the direction of travel is unmistakably positive—even if the destination remains a few quarters away.